Laura Ensign, PhD, is the Marcella E. Woll Professor of Ophthalmology with secondary appointments in Chemical & Biomolecular Engineering, Biomedical Engineering, Pharmacology and Molecular Sciences, Infectious Diseases, Gynecology & Obstetrics, and Oncology at Johns Hopkins University. Her research is focused on the principle of characterizing biological barriers in health and disease in order to design more efficacious formulations for prophylactic and therapeutic drug delivery. Her laboratory is a diverse group of scientists with expertise in biomaterials, chemistry, engineering, pharmacology, molecular biology, and computer science. Mentees from Laura’s group have pursued careers in various sectors, including the pharmaceutical industry, academia, venture, regulatory, and science policy and communication. Laura is a co-inventor of several drug delivery technologies, some of which that have led to FDA approved products or are in various stages of clinical trials. Laura has been actively involved in CRS for many years, most recently as the Chair of the Annual Meeting Planning Committee (AMPC) for the CRS 2023 Annual meeting. Laura is also the recent recipient of the Rising Women in Science Award, and a member of the College of Fellows. Laura is an Associate Editor for the Journal of Controlled Release and Drug Delivery and Translational Research.
Laura Ensign, Ph.D.
